3.3. Clinical severity of disease
Among patients positive for sole HAdV (n= 54) and sole RVA (n=353),
62.9, 79.6, 70.4 and 52.7, 88.7, 79.5 percent showed clinical history of
high body temperature, vomiting, and severe/very severe disease outcome
respectively. Statistically significant difference was not observed for
these parameters among sole HAdV and sole RVA patients as well as
patients with mixed infections (n=7) (p > 0.05 for each).
Comparison of the clinical features, of the AGE patients during the
study period is displayed in Table no.4. The mean values of the number
of days, number of episodes per 24 hr. of diarrhea and vomiting, body
temperature as well as severity score of the patients infected with RVA,
HAdV, mixed infection, and negative for both viral agents were compared.
The significantly high mean values of diarrheal episodes were observed
only in RVA patients as compared to the group of patients negative for
both HAdV and RVA (p= 0.006).
A total of 15 and 30 out of 61 HAdV positive and 97 and 180 out of 360
RVA positive patients showed > 5% and < 5%
degree of dehydration respectively. The comparative analysis of the HAdV
and RVA positive patients for degree of dehydration (<5%,
>5% and none) showed no significant difference (p
> 0.05 for each). Similarly 3 and 19 patients with oral
treatment (n=50) and 58 and 341 patients with intravenous treatment
(n=1117) were positive for HAdV and RVA, respectively. Comparison of
type of treatment used among these groups also showed no significant
difference (p > 0.05).